Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for healthcare industry professionals · Friday, March 29, 2024 · 699,712,485 Articles · 3+ Million Readers

HHS Secretary Azar Praises Merck’s Decision to Cut Drug Prices

Health and Human Services Secretary Alex Azar issued the following statement regarding Merck’s decision to substantially reduce prices for a number of drugs:

“The President’s blueprint for lower drug prices is working, drug prices are coming down, and American patients are going to see the savings in their pocketbook. We welcome Merck’s decision to reduce prices and restrain future price hikes.

“This decision is a response to President Trump’s blueprint and reflects the industry’s understanding that the President is serious about bringing change to our drug markets. Actions announced by HHS this week on over-the-counter drugs, biosimilars, and importation are helping to build a wholly new system that puts American patients first. More action is on the way.”

Read the President’s “American Patients First” blueprint.

 

Powered by EIN Presswire
Distribution channels: Healthcare & Pharmaceuticals Industry


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release